Verano Holdings Corp
CNSX:VRNO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Verano Holdings Corp
Operating Income
Verano Holdings Corp
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
V
|
Verano Holdings Corp
CNSX:VRNO
|
Operating Income
$66.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Operating Income
$26.8B
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Operating Income
$16.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
23%
|
CAGR 10-Years
23%
|
|
|
Pfizer Inc
NYSE:PFE
|
Operating Income
$19.9B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
14%
|
CAGR 10-Years
4%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Operating Income
$26.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
20%
|
CAGR 10-Years
12%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Operating Income
$29.7B
|
CAGR 3-Years
53%
|
CAGR 5-Years
34%
|
CAGR 10-Years
24%
|
|
Verano Holdings Corp
Glance View
In the burgeoning landscape of the cannabis industry, Verano Holdings Corp. emerges as a key player, crafting a narrative of growth and innovation. Founded with an ambition to bring premium cannabis products to the forefront of the market, Verano operates across a diverse array of segments, tapping into both the medicinal and recreational sectors. The company stands out due to its vertically integrated model, which means it controls the entire supply chain, from cultivation and production to distribution and retail. This model not only ensures quality and consistency but also allows Verano to capture value at every step of the process. Through meticulous cultivation practices and state-of-the-art facilities, Verano develops a wide range of products, including flower, edibles, and concentrates, which are distributed under its house of premium brands in various markets across North America. Verano's financial engine is powered by its extensive network of retail outlets—known as Zen Leaf and MÜV dispensaries—and its aggressive expansion strategy into emerging markets. This retail footprint is crucial, providing direct access to consumers and fostering a loyal customer base. Verano continuously enhances its product offerings by focusing on innovation and responding adeptly to consumer trends, thereby driving sales and margin growth. Its adept navigation of complex regulatory environments reflects a keen understanding of market dynamics, allowing it to take advantage of growth opportunities in a sector that remains highly regulated. By marrying operational efficiency with a deep commitment to delivering high-quality, consistent cannabis products, Verano not only sustains profitability but also positions itself strategically for future growth in an evolving industry landscape.
See Also
What is Verano Holdings Corp's Operating Income?
Operating Income
66.5m
USD
Based on the financial report for Dec 31, 2022, Verano Holdings Corp's Operating Income amounts to 66.5m USD.
What is Verano Holdings Corp's Operating Income growth rate?
Operating Income CAGR 1Y
11%
Over the last year, the Operating Income growth was 11%.